Form D · Biotechnology
Axenic Health Solutions, Inc.
Libertyville, IL · CIK 0001749418
Offering snapshot reported May 12, 2026 · SEC filing
- Reported sold
- $175K Offering amount: $1M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Mar 25, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 12, 2026 | Initial | $175,029 | No comparison | 3 | SEC filing |
| Sep 30, 2025 | Initial | $180,047 | No comparison | 4 | SEC filing |
| May 15, 2020 | Amendment | $3,184,985 | $2,684,985vs Apr 24, 2019 | 13 | SEC filing |
| Jul 3, 2019 | Amendment | $500,000 | $0vs Apr 24, 2019 | 1 | SEC filing |
| Apr 24, 2019 | Initial | $500,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-583784
Source: Form D, filed May 12, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Patrick Beyer | Director |
| Todd Evans | Director, Executive |
| Ahmad Gaber | Director |
| Warren Skea | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1020 Windhaven Road
Libertyville, IL, 60048
Libertyville, IL, 60048